Stock analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP – Get Rating) in a report released on Sunday. The firm set a “hold” rating on the stock.
Separately, TheStreet cut shares of Retractable Technologies from a “c-” rating to a “d+” rating in a research note on Tuesday, June 13th.
Retractable Technologies Stock Performance
Shares of NYSE RVP opened at $1.17 on Friday. The firm’s 50-day moving average price is $1.37 and its 200-day moving average price is $1.70. The company has a quick ratio of 6.46, a current ratio of 8.60 and a debt-to-equity ratio of 0.01. The company has a market cap of $35.03 million, a PE ratio of -23.40 and a beta of 2.17. Retractable Technologies has a 52-week low of $1.04 and a 52-week high of $5.17.
Hedge Funds Weigh In On Retractable Technologies
Several institutional investors have recently made changes to their positions in RVP. Cubist Systematic Strategies LLC bought a new stake in shares of Retractable Technologies during the second quarter valued at approximately $40,000. Royal Bank of Canada raised its position in shares of Retractable Technologies by 29.7% during the first quarter. Royal Bank of Canada now owns 13,265 shares of the company’s stock valued at $63,000 after buying an additional 3,037 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in shares of Retractable Technologies in the second quarter valued at $54,000. Virtu Financial LLC purchased a new position in shares of Retractable Technologies in the second quarter valued at $57,000. Finally, FMR LLC grew its holdings in shares of Retractable Technologies by 190.0% in the second quarter. FMR LLC now owns 16,216 shares of the company’s stock valued at $62,000 after purchasing an additional 10,625 shares in the last quarter. Institutional investors own 14.79% of the company’s stock.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Recommended Stories
- Get a free research report on Retractable Technologies from StockNews.com
- MarketBeat Week in Review – 6/19 – 6/23
- CarMax Stock Flying On Earnings Beat, Return Of The Highs?
- Commercial Metals Company Shakes Off The Rust: Confirms Uptrend
- Smith & Wesson, A Timeless Value Play At Decade Lows
- Five stocks we like better than Retractable Technologies
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
